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 The aim is to evaluate the effect of modifying poly[( L -lactide)-co-
(ε-caprolactone)] scaffolds (PLCL) with nanodiamonds (nDP) or with 
nDP+physisorbed BMP-2 (nDP+BMP-2) on in vivo host tissue response and 
degradation. The scaffolds are implanted subcutaneously in Balb/c mice 
and retrieved after 1, 8, and 27 weeks. Molecular weight analysis shows that 
modifi ed scaffolds degrade faster than the unmodifi ed. Gene analysis at 
week 1 shows highest expression of proinfl ammatory markers around nDP 
scaffolds; although the presence of infl ammatory cells and foreign body giant 
cells is more prominent around the PLCL. Tissue regeneration markers are 
highly expressed in the nDP+BMP-2 scaffolds at week 8. A fi brous capsule is 
detectable by week 8, thinnest around nDP scaffolds and at week 27 thickest 
around PLCL scaffolds. mRNA levels of ALP, COL1α2, and ANGPT1 are 
signifi cantly upregulating in the nDP+BMP-2 scaffolds at week 1 with ectopic 
bone seen at week 8. Even when almost 90% of the scaffold is degraded at 
week 27, nDP are observable at implantation areas without adverse effects. In 
conclusion, modifying PLCL scaffolds with nDP does not aggravate the host 
response and physisorbed BMP-2 delivery attenuates infl ammation while 
lowering the dose of BMP-2 to a relatively safe and economical level. 
 1.  Introduction 
 The limitations of current bone recon-
struction techniques have led to increased 
interest in developing improved scaffolds 
for bone tissue engineering (BTE). [ 1 ] Cur-
rently, the “golden standard” clinical 
treatment of large bone defects include 
autografts or allografts. [ 2 ] Despite pre-
senting successful healing, however, they 
carry drawbacks such as donor site mor-
bidity, disease transmission, and immune 
rejections. [ 2 ] Synthetic polyesters have 
been used in the biomedical fi eld and 
for producing scaffolds for BTE for dec-
ades. [ 3 ] Degradable copolymers such as 
poly[( L -lactide)-co-(ε-caprolactone)] (PLCL) 
produced by copolymerization have 
been recently exploited for BTE scaffolds 
due to their in vitro cytocompatibility, [ 4 ] 
osteogenic conductivity [ 5 ] in addition to 
tuneable mechanical and degradable 
properties. [ 6 ] Also, scaffolds produced by 
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blending of poly( L -lactide) and polycaprolactone in different 
proportions signifi cantly improved human stem cell attach-
ment and growth when compared to homopolymers. [ 7 ] This 
blended polymer also exhibited characteristics favorable for 
bone regeneration in critical defects in ovine tibiae. [ 8 ] 
 It has been shown that the nanoscale architecture of bioen-
gineered scaffold materials generates bioactive scaffolds, which 
can substitute for the native extracellular matrix and enable 
spatiotemporal release of relevant growth factors. [ 9 ] Carbon-
derived nanodiamond particles (nDP) have gained wide atten-
tion in medical technology owing to their chemical stability 
and biocompatibility. [ 10 ] Recent reports have demonstrated that 
nDP with oxygen-containing terminal groups (mostly hydroxyl) 
enhance the hydrophilic properties of copolymer scaffolds, thus 
enhancing cellular responses and subsequent bone forma-
tion. [ 11 ] (PLCL) scaffolds and nDP have also shown to provide a 
promising delivery modality for low controlled amounts of oste-
ogenic growth factors such as bone morphogenetic protein 2 
(BMP-2). [ 12 ] Previously BMP-2 has been applied in supraphysi-
ological doses for adequate bone regeneration. [ 13 ] 
 An implanted scaffold can act as a foreign material and the 
protein interactions at their surface are crucial for the nature of 
the host response toward it. [ 14 ] An implanted scaffold initiates 
a series of events similar to a foreign body reaction, starting 
with an acute infl ammatory response and leading in some 
cases to a chronic infl ammatory response and/or granulation 
tissue development, a foreign body reaction and fi brous cap-
sule development. The chemical composition of the scaffold, its 
surface charge, porosity, topography, size, and shape affects the 
intensity and duration of each of the steps of this cascade. [ 15 ] 
Hence, functionalizing a scaffold with nDP may affect the 
host’s tissue response. Titania [ 16 ] and tripolyphosphate nano-
particles [ 17 ] have been shown to improve the biocompatibility 
of poly(lactic-co-glycolic acid) scaffolds, while nondegradable 
nanoparticles made of silica have been shown to induce infl am-
mation. [ 18 ] Infl ammatory cell interactions signifi cantly impact 
the biocompatibility and function of implanted scaffolds and 
can eventually cause their clinical failure [ 19 ] or success. For 
instance, local infl ammation is required to initiate the process 
of tissue regeneration and its control is considered necessary to 
guide the normal regeneration of damaged tissues. However, 
both defi cient and excessive infl ammation can negatively affect 
the tissue regeneration process. [ 20 ] BMP-2 in high uncontrolled 
amounts have been used for bone regeneration clinically and 
occasionally been reported to cause unfavorable tissue effects, 
ranging from soft tissue edema, erythema, “unwanted” exag-
gerated infl ammation, and immune response. [ 21 ] The control of 
infl ammatory response to enhance bone regeneration has been 
extensively studied, [ 22 ] and it is widely believed that control of 
these responses leads to a diminished foreign body reaction 
and increased bone regeneration. [ 23 ] 
 To be used in regenerative medicine, a bioengineered scaf-
fold must have good biocompatibility in the host tissue. [ 24 ] 
The degradation profi le of a bioactive scaffold is essential, as it 
should degrade at a rate approximating the rate of tissue resto-
ration while maintaining release of the appropriate concentra-
tion of the incorporated BMP-2. Also, neither the scaffold nor 
the by-products should be toxic. [ 1 ] The lack of adverse tissue 
responses to the scaffold delivering a growth factor in a host 
is one of the critical requirements of a tissue engineering con-
struct in addition to supporting suitable cellular action and ena-
bling molecular and mechanical support. [ 25 ] The degradation 
profi le of pristine poly[( L -lactide)-co-(ε-caprolactone)] (PLCL) 
scaffolds has been previously reported, however only for up to 
13 weeks in vivo. [ 26 ] The effect of nDP modifi cation and BMP-2 
physisorption on the degradation of these scaffolds has not 
been studied yet. Thus, the main objective of this work was to 
determine in vivo the effect of functionalizing PLCL scaffolds 
with nDP and nDP plus BMP-2 on degradation and on the 
infl ammatory and healing response up to 27 weeks. 
 2.  Materials and Methods 
 2.1.  Scaffold Fabrication 
 The poly[( L -lactide)-co-(ε-caprolactone)] was synthesized by 
bulk-ring opening polymerization of the monomers  L -lactide 
(Boehringer Ingelheim,Germany) and ε-caprolactone 
(Sigma-Aldrich, St Louis, MO, USA) as described earlier. [ 5 ] 
Briefl y,  L -lactide was purifi ed by recrystallization in dried tol-
uene for three times. The ε-caprolactone was dried through 
calcium hydride at room temperature overnight and distilled 
at 80 °C for purifi cation. The components of monomers, ini-
tiator (ethylene glycol) and catalyst (stannous 2-ethylhexanoate) 
were loaded under inert environment. The reaction was per-
formed under 110 °C for 72 h and precipitated three times in 
cold hexane and methanol to remove unreacted monomers. [ 5 ] 
The number average molecular weight ( M n ) of the purifi ed 
copolymer was ≈100 000 Da and molar mass dispersity 
( Ð m ) ≈1.3 determined by size exclusion chromatography (SEC) 
(Polymer Laboratories, U.K.). The copolymer was composed of 
75 mol %  L -lactide and 25 mol% ε – caprolactone, confi rmed by 
proton nuclear magnetic resonance ( 1 H NMR) (Bruker Avance 
400, Billerica, MA, USA). 3D porous scaffolds were prepared by 
the solvent-casting particulate leaching method described ear-
lier. [ 5,6 ] The copolymer was dissolved in chloroform (1 g mL −1 ) 
and mixed with sodium chloride particles by a weight ratio of 
10:1 before being poured into molds. Scaffolds were punched 
out in a disc shape of (diameter ≈6 mm, thickness ≈1.3 mm). 
Salt particles were removed by soaking in deionized water and 
then scaffolds were vacuum dried and electron beam sterilized. 
Scaffold porosities before and after modifi cation with nanodia-
mond alone or nanodiamond and BMP-2 were characterized 
using a micro-CT (SkyScan 1172, Kontich, Belgium) using 
33 kV, 9 µm voxel, 0.4° rotation step and no fi lter. 3D recon-
struction images were constructed with the software CT-Ana-
lyzer (v 1.13, Bruker). 
 2.2.  Colloidal nDP Production and Scaffolds Modifi ed with nDP 
Plus Physisorbed BMP-2 (nDP and nDP+BMP-2 Scaffolds) 
 Recombinant BMP-2 and colloidal nanodiamond particles 
were produced as previously described and the PLCL scaffolds 
modifi ed as previously reported. [ 12 ] Briefl y, BMP-2 expressed 
in Escherichia coli ( E. coli ), isolated from inclusion bodies, 
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renatured and purifi ed. Each scaffold contained 1 µg of BMP-2. 
Acid purifi ed detonation diamond (Gansu Lingyun Corp., Lan-
zhou, China) was subjected to attrition milling using a method 
previously described [ 27 ] achieving a narrow size distribution at 
≈5 nm particle diameter (measured by dynamic light scattering 
in water) and very low agglomeration of the diamond particles. 
Scaffolds were modifi ed with the nDP solution (2 wt%, i.e., 
20 mg mL −1 ) by a vacuum technique: 0.5 mL nDP solution and 
one scaffold were put in a glass beaker and perfused in vacuum 
(Oerlikon Leybold, TRIVAC D 65B). The vacuum chamber was 
evacuated down to the pressure where the nDP-water solution 
changes into vapor phase and the nDP burst into the scaffold 
surface. This cycle was repeated 10 times. After treatment, the 
nDP modifi ed scaffolds were rinsed with distilled water and 
dried in vacuum for 8 h. To quantify the increase of the surface 
due to nDP retained in the scaffold, the Brunauer–Emmet–
Teller (BET) isotherm was determined using N 2 at 77 K using 
an ASAP 2420 surface area and porosimetry system (Micromer-
itics). An increase of surface area after modifi cation with nDP 
by factor 30 could be determined providing a large interactive 
area for subsequent physisorption with BMP-2. Quantitative 
measurement of the nDP in the scaffolds has been controlled 
for quality by induction furnace combustion for quantifi cation 
of inorganic carbon amounts in solid materials. 
 BMP-2 was physisorbed onto unmodifi ed PLCL scaffolds as 
follows: scaffolds were placed on a sterilized parafi lm (M Barrier 
Film, Parafi lm and 1 µg of BMP-2/ 50 µL phosphate buffered 
saline (PBS) was dropped as two equal portions onto the sur-
face of the scaffold. The fi rst aliquot was allowed to adsorb 
after which the second aliquot was added before the scaffold 
was used. Unmodifi ed copolymer scaffolds are abbreviated as 
PLCL scaffold and copolymer scaffolds modifi ed with nDP are 
abbreviated as nDP scaffold and scaffolds modifi ed with nDP 
plus physisorbed with BMP-2 are abbreviated as nDP+BMP-2 
scaffold. 
 2.3.  Mouse Ectopic Subcutaneous Implantationn 
 Thirty female Balb/c mice (6–8 weeks) were anesthetized with 
Isofl urane (Isoba VetTM) (Schering Plough, Kenilworth, NJ, 
USA) before two incisions (1 cm) were made on their back. 
One incision was made between the upper limbs and another 
between the lower limbs. Four scaffolds were implanted into 
each mouse and the different groups (PLCL scaffolds, nDP 
scaffolds, and nDP+BMP-2 scaffolds) were distributed among 
all mice ( n = 8 scaffolds per time point). Wounds were closed 
with Histoacryl tissue adhesive (B. Braun Surgical AS, Ger-
many). Animals were sacrifi ced with CO 2 overdose at 1, 8, and 
27 weeks after implantation. The samples were retrieved and 
stored in RNAlater (Invitrogen, Carlsbad, CA, USA) for quan-
titative real-time reverse transcribed polymerase chain reaction 
(RT-PCR), micro-CT, and histological analyses. 
 2.4.  Copolymer Composition and Molecular Weight Analysis 
 The harvested samples after 1, 8, and 27 weeks were dissolved in 
chloroform. Number average molecular weights were recorded 
by SEC on a Verotech PL-GPC 50 (Polymer Laboratories, Varian 
Inc., MA, USA), equipped with a refractive index detector 
and two Polar-Gel-M organic GPC columns (300 × 7.5 mm) 
from Varian Inc. Samples were injected using a PL-AS RT 
auto sampler, using chloroform at a fl ow rate of 1mL min −1 as 
eluent. The system was calibrated against narrow polystyrene 
standards (Part No. PL2010-0301, range 162–371, 100 g mol −1 , 
Varian Inc.). The data were analyzed by Cirrus GPC software. 
An average of 2 samples is presented in the results. Molecular 













 2.5.  Gene Analysis by Customized RT 2 Profi ler PCR Array 
 Total RNA was isolated from the in vivo samples after week 1 
and week 8 using a Tissue RNA isolation kit (Maxwell, Pro-
mega, Madison, WI, USA) and reverse transcribed according 
to the manufacturer’s instructions using the Rt 2 PCR array 
First Strand Kit (SABiosciences, Hilden, Germany). A custom-
ized Rt 2 Profi ler PCR Array (SABiosciences) including selected 
infl ammatory, osteogenic, and angiogenic probes was used and 
PCR was performed on a StepOne Plus real time PCR system 
(Applied Biosystems,Carlsbad, CA, USA) with Rt 2 Real-time 
SyBR Green/Rox PCR mix (Superarray Bioscience). The genes 
included in the assay are summarized in  Table  1 . 
 2.7.  Descriptive Semiquantitative Histological Evaluation 
 Retrieved samples were fi xed in 4% paraformaldehyde then 
decalcifi ed over one week using 10% EDTA in 0.1 M Tris buffer 
and 7.5 % Polyvinylpyrrolidone (Merck & Co, White House 
Station, NJ, USA) before embedding in paraffi n. Sections of 
3–4 µm were stained with hematoxylin/eosin (H&E) (Sigma, 
St Louis, MO, USA). Qualitative and semiquantitative histolog-
ical evaluation was carried out to assess the tissues’ response to 
the implanted scaffolds. Sections were evaluated blindly by two 
of the authors (S.S. and D.E.C, one is a pathologist) under a light 
microscope (Leica, Solms, Germany). The presence and quality 
of fi brous capsules and the type and amounts of cells were ran-
domly evaluated in six fi elds of vision (magnifi cation 400×) of 
the entire implant area of each section using a modifi ed scoring 
system. [ 28 ] Histopathological examination of tissue specimens 
was limited to the tissue inside the scaffold and that in direct 
contact with it, evaluating the presence of different types of cells: 
those involved in early responses (neutrophils and plasma cells) 
and those involved in late or chronic responses (lymphocytes 
and foreign body giant cells). The grading for histological 
scoring is summarized in  Table  2 . 
 The histological sections were also visualized with an 
ultraresolution imaging system (Cytoviva 130, Auburn 
USA) consisting of a customized condenser (high resolution 
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with ≈6–8 µm pixel size, 50 kV, aluminum 0.5 mm fi lter, and 
0.4° rotation step. 3D reconstruction images were constructed 
with the software CT-Analyzer (v 1.13, Bruker). 
 2.9.  Statistical Analysis 
 The average values were analyzed using SPSS Statistics 
21.0 (IBM, Armonk, NY, US). RT-PCR data were analyzed using 
the web-based analysis software RT 2 Profi ler PCR Array Data 
Analysis (v 3.5, Superarray Bioscience) and expressed as the 
mean with 95% confi dence interval (CI). Other results were 
expressed as mean ± standard deviation (SD) and analyzed 
using One-way ANOVA followed by a multiple-comparison 
Tukey test. Differences between the means was considered 
statistically signifi cant when p < 0.05. 
 2.10.  Ethical Statement 
 All animal experiments were approved by the Norwegian 
Animal Research Authority and conducted in strict accordance 
with the European Convention for the Protection of Vertebrates 
used for Scientifi c Purposes (FOTS no. 20135042). All proce-
dures were performed under isofl urane gas anesthesia, and all 
efforts were made to minimize suffering. 
 3.  Results 
 3.1.  Functionalizing Poly(LLA-co-CL) Scaffolds with nDP 
and nDP+BMP-2 Expedite their Degradation 
 Modifying the PLCL scaffolds with nDP or nDP+BMP-2 did 
not affect the porosity or pore distribution of the scaffolds 
 Table 2.  Histological grading scale for tissue response. 
 Histological grading scales  Score 
 Grading scale for capsule thickness  
 Not applicable 1
 1–4 concentric layers of fi broblasts 2
 5–9 concentric layers of fi broblasts 3
 >30 concentric layers of fi broblasts 4
 Grading scale for capsule quality  
 Not applicable 1
 Infl ammatory cells with no fi bers 2
 Both fi bers and infl ammatory cells 3
 Collagen fi bers 4





 Table 1.  Functional grouping of the genes evaluated. 
 Gene  Full name 
 Infl ammatory cytokines and chemokines 
CCL5 Chemokine (C–C motif) ligand 5-RANTES
IL 10 Interleukin 10
IL 4 Interleukin 4
IL 1a Interleukin 1 alpha
IL 1b Interleukin 1 beta – Catabolin
IL 6 Interleukin 6
TNFα Tumor necrosis factor alpha
CSF1 Colony stimulating factor 1
CCL12 Chemokine (C-C motif) ligand 12
CXCR2 Chemokine (C-X-C motif) receptor 2
PECAM1 Platelet/endothelial cell adhesion molecule 1
MMP9 Matrix metallopeptidase 9
 Osteogenic markers 
COL1α2 Collagen, type 1, alpha 2
COL2α1 Collagen, type 2, alpha 1
COL1α1 Collagen, type 1, alpha 1
ALP Alkaline phosphatase
RUNX2 Runt-related transcription factor 2
BMP- 2 Bone morphogenetic protein 2
BMP-4 Bone morphogenetic protein 4
BMP-7 Bone morphogenetic protein 7
SOX9 Transcription factor sox 9
BMPR1A Bone morphogenetic protein receptor 1A
BMPR2 Bone morphogenetic protein receptor 2
 Angiogenic markers 
VWF Von Willebrand factor
VEGFA Vascular endothelial growth factor A
FGF2 Basic fi broblast growth factor
ANGPT1 Angiopoietin 1
ANGPT2 Angiopoietin 2
 Endogenous references 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
B2M Beta-2 microglobulin
ACTβ Actin beta
illuminator) connected to a research grade optical microscope 
(Olumpus, BX41) and a powerful light source (EXF0120, 
Photonic Solution) equipped with a (100×) oil immersion 
objective. Images were captured with a cooled camera (model 
XLMCT, Dage-MTI, USA) and DageXponent software (v 1.3, 
Dage-MTI, USA). 
 2.8.  Microcomputed Tomography 
 The amount of mineralized tissue (bone formation) within the 
scaffolds was examined using micro-CT (Skyscan 1172, Bruker) 
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(Figure S1A,B, Supporting Information). 
The porosity of the different scaffolds was 
88.5%, 86.8%, and 86.1% for PLCL, nDP, 
and nDP+BMP-2, respectively (Figure S1A, 
Supporting Information). After implantation, 
uneventful wound healing was observed at 
all time points and no notable macroscopic 
differences were observed in the implanta-
tion sites of the different scaffolds. No signs 
of systemic or neurological toxicity occurred 
during the observation period. The obser-
vations were based on lack of infection in 
surgical wound area, loss in weight (>10%), 
abnormal movement or immobility and ung-
roomed fur. 
 In vivo degradation of the different scaf-
folds was seen macroscopically and the pro-
fi le was determined by the percentage loss 
in number average molecular weight of the 
polymer ( Figure  1 A). A dry scaffold repre-
senting each group from every time point 
is shown in (Figure  1 C–F). Macroscopically 
they were seen to retain their general round 
shape and structure up to week 8. At week 
27 the scaffolds became considerably thinner 
and translucent in central areas, which made 
them more susceptible to tearing. Molecular 
weight analysis showed that between week 1 
and week 8 the rate of degradation was dif-
ferent for the different scaffolds. At week 1 
more molecular weight loss was observed 
from the nDP and nDP+BMP-2 scaffolds 
than from the PLCL scaffolds. This trend was 
also seen at week 8, where the modifi ed scaf-
folds lost more molecular weight than the 
PLCL scaffolds. At week 27 almost 90% of 
the polymer had degraded from all scaffold 
types. Images taken with ultrahigh resolution 
imaging (Cytoviva) microscopy showed that 
the nDP were still present in the implanta-
tion tissue area at week 27 (Figure  1 G). 
 3.2.  In Vivo Host Response and Expression 
of Infl ammatory Markers 
 Gene analysis of the pro-infl ammatory 
markers (cytokines) displayed a general 
upregulated expression at week 1 and rela-
tive downregulation at week 8 ( Figure  2 A). 
Early infl ammatory chemokines (CCL5 and 
CCL12) were highly expressed in the modi-
fi ed group scaffolds compared to PLCL at 
week 1 and then signifi cantly downregulated 
in all groups at week 8. IL6 showed signifi cant 
upregulation for nDP at week 1. TNFα and 
IL10 showed a signifi cant downregulation for 
all groups at week 8. However, markers of 
late/chronic infl ammation or tissue healing 
 Figure 1.  Implantation pattern, degradation behavior of implanted scaffolds and fate of incor-
porated nanodiamond particles. A) Molecular weight loss of the different scaffolds measured 
by SEC expressed in percentage depicting their degradation profi le (average of two independent 
measurements). B) Subcutaneous implantation of four random scaffolds per animal. Macro-
scopic images of the scaffolds C) before implantation, D) 1 week postimplantation, E) 8 weeks 
postimplantation, F) 27 weeks postimplantation. A thin fi brous tissue coating on retrieved 
scaffolds is indicated by the red arrow. G) Images taken with Cytoviva showing the abundant 
presence of nDP in the implantation site even after 27 weeks. Magnifi cation 1000×. Bright areas 
are the nanodiamonds. Pores are invaded with tissue ingrowth as seen in green color and the 
cell nuclei are observed as red dots (white arrows).








735wileyonlinelibrary.com© 2016 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
(IL4, MMP9, PECAM1) showed the reversed pattern, with 
upregulation at week 8 and the greatest expression from nDP or 
nDP+BMP-2 group. 
 Infl ammatory activity was also estimated histologically by 
the host tissue response at weeks 1, 8, and 27. Representative 
sections (H&E staining) of the different scaffolds explanted 
at week 1 are presented in ( Figure  3 ). The void spaces histo-
logically observed between tissues and cells represent the cross 
sections of the scaffolds. At week 1 the connective tissue was 
loose, with thin collagen fi bers and a thin layer of host cell 
 Figure 2.  Infl ammatory cytokine and chemokine expressions. A) Clustergram showing relative mRNA expression of preselected pro- and 
anti-infl ammatory markers from the cells that infi ltrated in the scaffolds at week 1 and 8. B) Some of the signifi cantly expressed genes plotted as quan-
titative fold change in the y-axis. Data are expressed as 2 −ΔΔCt and 95% confi dence interval relative to PLCL group at week 1. Values were normalized 
with the arithmetic mean of β-Act, GAPDH, and B2M. (* p < 0.05, ** p < 0.001.)
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infi ltration seen at the interface between host and scaffold. 
The infl ammatory infi ltrate consisted predominantly of neu-
trophils and lymphocytes at week 1, mainly at the periphery 
of the scaffold, diminishing toward the center of the scaffold 
(Figure  3 A,C,E). The presence of acute infl ammatory cells 
was more prominent in the PLCL scaffold group (neutrophils 
p < 0.01, plasma cells p < 0.01) than in the other groups ( Figure  4 ). 
At week 8 the pores were mainly occupied by fi brous tissue 
containing fi broblasts. Infl ammatory cells (lymphocytes and 
plasma cells) were still visible in the porous structure at week 
8 after implantation; however, their presence reduced at 27 
weeks. As the infl ammatory response became chronic, cells 
appeared to be increased toward the inner porous structure of 
the scaffold. Multinucleated foreign body giant cells (FBGC) 
were not seen at week 1 in any of the groups. Their presence 
was observed at week 8 and increased with time, except in 
nDP+BMP-2 scaffolds, where fewer FBGC were seen at week 
27 than at week 8 (Figure  4 ). PLCL scaffolds were observed to 
recruit higher numbers of FBGC than other scaffold groups 
and this corresponded with their molecular weight loss. The 
morphology of the FBGC was typical for a foreign body reac-
tion, with irregular shape and more than 20 nuclei distributed 
randomly within their cytoplasm. 
 Degradation of scaffolds, as assessed microscopically on 
the histological sections, was observed as a loss of the regular 
appearance of the scaffold and its replacement by fi bers. Rem-
nants of scaffold material could be observed histologically at 
week 8 ( Figure  5 B ‘S’) predominantly at the center, indicating 
that the scaffolds degraded more at the periphery than at the 
center. FBGC were seen commonly very close to the remnants 
of the material (Figure  5 A–C, red arrows). No macroscopically 
detectable fi brous capsule was seen at week 1 in all scaffold 
 Figure 3.  Infl ammatory reaction of host tissue. Images of H&E stained sections at week 1 postimplantation. (A, C, and E) PLCL, nDP, nDP+BMP-2, 
respectively, show the infl ammatory cell infl ux greatest at the periphery. Magnifi cation 25×. Scale bar = 1 µm. (B, D, and F) PLCL, nDP, nDP+BMP-2, 
respectively, at 400× magnifi cation show examples of the different scaffolds in the three groups at week 1 postimplantation showing the different 
infl ammatory cells recruited. N – neutrophils, L – lymphocytes, P – plasma cells. Scale = 100 µm. 
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groups, but at week 8 and 27 after implantation, a very thin 
fi brous tissue surrounding the samples and strongly attached 
to them was observed (Figure  1 E,F, red arrows). Generally, at 
week 8, the capsule was seen in all groups, with an average of 
less than nine concentric layers of fi broblasts observed micro-
scopically (Figure  5 D–F) and containing collagen fi bers with 
few infl ammatory cells. By week 27, the capsule was mostly 
fi brous and its thickness was reduced to less than four concen-
tric fi broblast layers on average in all groups. The PLCL scaffold 
was surrounded by the thickest capsule (Figure  4 ). 
 3.3.  Angiogenic and Ectopic Bone Stimulation 
 The osteogenic potential and angiogenic effi cacy of the different 
scaffolds was evaluated at the molecular level by RT-PCR of 
selected markers signifi cant for both ( Figure  6 A,B). Osteogenic 
potential of the scaffolds was further evaluated by ectopic bone 
formation/mineralization by micro-CT. mRNA of BMPR1A 
and RUNX2 were signifi cantly upregulated in the nDP+BMP-2 
scaffold group at week 1. MRNA levels of ALP (p = 0.01) also 
showed a pronounced upregulation at week 1 stimulated by 
BMP-2. At week 8 ALP downregulated in nDP-PHY scaffolds 
but continued to be highly expressed in other groups. Collage 
type 1 and type 2 markers (mRNA Col1a2 and Col2a1, respec-
tively) also showed a similar trend of signifi cant highest expres-
sion in nDP+BMP-2 followed by nDP at week 1 and week 8. 
 mRNA levels of angiogenesis markers were all seen to be 
signifi cantly upregulated at week 8 in all groups. Generally, 
nDP and nDP+BMP-2 scaffolds were seen to have higher 
expressions compared to CL at week 1. nDP+BMP-2 showed 
a signifi cant upregulation of ANGPT1 (p = 0.03) and FGF2 
(p = 0.003) at week 1. 
 Subcutaneous implantation of the scaffolds lead to pro-
nounced ectopic bone formation in nDP+BMP-2 scaffolds. 
A representative 3D reconstruction of nDP+BMP-2 scaffold 
 Figure 4.  Histological grading of early and late infl ammatory cells at weeks 1, 8, and 27 for the three different scaffold types. Average score in the y-axis 
and data expressed with SD. (* p < 0.05, ** p < 0.001.) Stars (*) without lines express signifi cance between groups at different time points. 
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to modify the scaffolds has been shown to increase the hydro-
philicity of the scaffolds and hence improve cellular attachment 
and differentiation [ 11 ] due to the hydroxylated surfaces. [ 29 ] This 
also enhanced the absorption of water and thus accelerated 
the hydrolysis process causing the higher molecular weight 
loss from nDP and nDP+BMP-2 scaffolds relative to PLCL at 
week 1 and week 8. The degradation analyzed after week 1 is 
relatively fast, but may be the result of pre-existing water sol-
uble low molecular weight oligomers created during steriliza-
tion being leached out without need for chain cleavage. [ 26 ] It 
was also observed that the increased water diffusion into the 
nDP modifi ed scaffolds may have promoted a bulk pattern of 
erosion. In bulk erosion, the polymer chain scission occurs 
throughout the scaffold in the amorphous part of the polymer, 
thus although it does not change much in external dimen-
sions, the molecular weight decreases early. This was seen in 
the macroscopic pictures (Figure  1 ) of the harvested scaffolds 
after 8 and 27 weeks where the nDP and nDP+BMP-2 scaffolds 
scanned after 8 weeks postimplantation showing the mineral-
ized tissue (Figure  6 C,D). 
 4.  Discussion 
 The biocompatibility of the polymeric scaffolds was evaluated 
utilizing a standard, previously established subcutaneous mouse 
model for determining tissue responses to biomaterials. [ 26 ] This 
in vivo model more closely refl ects the natural situation than in 
vitro assessments. 
 The degradation profi le of unmodifi ed PLCL scaffolds has 
been evaluated previously. [ 26 ] In the current study, the explanted 
scaffolds were extracted with chloroform, and the polymeric 
residue was weighed and analyzed, thus demonstrating that 
the degradation of the scaffolds occurred by polymer chain 
cleavage, resulting in a reduction of molecular weight. These 
polyesters are known to degrade by hydrolysis. The nDP used 
 Figure 5.  Light images of H&E stained scaffolds at week 8 postimplantation. A–C) PLCL, nDP, and nDP+BMP-2, respectively, showing the different 
foreign body giant cells (red arrows) and the remnant scaffold indicated “S,” D–F) PLCL, nDP, and nDP+BMP-2, respectively, and show the varying 
thickness of the capsules “CAP” surrounding the different scaffolds at week 8. Magnifi cation 200×. Scale bar = 200 µm. G–I) Magnifi cation 400× of the 
different fi brous capsules. Scale bar = 100 µm. 
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week 1 (Figure  2 ) relative to the PLCL scaffolds, suggesting the 
presence of the early stage reactive oxygen species, which has 
been reported to degrade polymers. The reactive oxygen species 
induce migration of infl ammatory cells that can oxidize polymer 
were physically present but showed considerably thinner and 
translucent areas in the centre. Tissue response also plays a 
role in in vivo degradation. The nDP modifi ed scaffolds exerted 
an upregulated infl ammatory response at the mRNA level at 
 Figure 6.  Osteogenic and angiogenic potential of the different scaffolds. A) Clustergram showing relative mRNA expression of preselected angiogenic 
and osteogenic markers from the cells infi ltrating the scaffolds after week 1 and 8. B) Some representative signifi cantly expressed genes plotted in a 
quantitative fold change in the y-axis. Data were expressed as 2 −ΔΔCt and 95% confi dence interval relative to PLCL group at 1 week. Values were normal-
ized with the arithmetic mean of β-Act, GAPDH and B2M. (* p < 0.05, ** p < 0.001.) C) Micro-CT 3D reconstructed image D) lateral image. E) Image 
with H&E staining, red arrow indicating mineralized area. Magnifi cation 400×. Scale bar = 100 µm. 
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levels produced by macrophages as a result of the faster deg-
radation of nDP modifi ed scaffolds relative to PLCL. Other 
studies also postulate that although the number of infl am-
matory cells is reduced in hydrophilic surfaces, but they are 
more activated thus releasing higher cytokine amounts. [ 15,34 ] 
However, the assessment of cytokines in vivo is challenging 
due to the local nature of their production and effects and the 
complex cellular interactions of a wide range of cytokines at 
any given time point. 
 The nDP+BMP-2 scaffolds carried BMP-2 and have previ-
ously been shown to sustain release of BMP-2 at low doses. [ 12 ] 
Since BMP-2 belongs to the TGF-β superfamily of proteins and 
TGF-β is known to have a dual role in infl ammatory modu-
lation, reducing TNFα production and promoting extracel-
lular matrix production. [ 35 ] The sustained release of BMP-2 
may explain the reduced levels of TNFα mRNA seen with 
nDP+BMP-2 scaffolds relative to nDP scaffolds. This result 
supports previous observations that slow BMP-2 release atten-
uated infl ammation [ 36 ] and enhanced osteogenic potential. 
Another recent study also observed the expression of TNFα 
to be increased in a nonmodifi ed collagen-chitosan scaffold 
compared to a modifi ed version delivering growth factors from 
chitosan nanoparticles. [ 37 ] Alternatively, it is also possible that 
the functional terminals in nDP are occupied with the bound 
BMP-2, thus preventing the nDP from infl uencing host tissue 
responses. 
 The tissue samples were cut in half before being embedded; 
hence all the sections were produced from the same location for 
standardized histological evaluation. Neutrophils are the fi rst 
line of defense in an infl ammatory reaction, [ 31 ] and they were 
seen in all scaffold groups, suggesting that the host response 
was in an early/acute infl ammatory stage during the fi rst week. 
However, a signifi cant increase in neutrophils was seen in the 
PLCL scaffolds at week 1 relative to the other scaffolds. This 
may be related to the surface properties of the different scaf-
folds and the initial variations in protein adsorption with sub-
sequent effects on cell activation, recruitment and adherence. 
Polymers with increased hydrophobicity have been revealed to 
increase infl ammatory cells’ (monocytes) attachment. [ 38 ] PLCL 
scaffold being relatively hydrophobic (around 80°, measured 
by water contact angle), [ 39 ] these scaffolds would also have 
greater affi nity for body fl uid proteins than the modifi ed scaf-
folds, which might lead to conformational changes in the pro-
teins due to the hydrophobic interactions that are thought to 
be responsible for recruiting infl ammatory cells and causing 
a pronounced foreign body reaction. [ 31,40 ] After week 8, the 
majority of cells seen in all specimens were mononuclear and 
giant cells, representing the typical foreign body response to 
biomaterials. The formation of FBGC is through the fusion of 
macrophages adherent to the implanted scaffold. The number 
of FBGC formed is related to degradation material. [ 19 ] The 
greatest number of FBGC was seen in the PLCL scaffolds at 
week 8, consistent with that this group being the least degraded 
scaffold at that time point and thus having more material avail-
able to be degraded. Although the nDP+BMP-2 had the next 
greatest score for FBGC at week 8, it was the fastest to degrade 
compared to other groups. This can be attributed to the upreg-
ulated IL4 mRNA levels of for that group at week 8, which 
has been reported to directly induce formation of FBGC. [ 41 ] 
chains. [ 30 ] Previously, it was demonstrated that the PLCL scaf-
folds implanted in rat calvaria decrease their molecular weight 
by around 70% after 91 days. [ 26 ] Regarding these same unmodi-
fi ed scaffolds, our study showed in two months almost 60% of 
 M n is reduced. Hence comparable rate of degradation is seen 
although the implantation site and size of animal was different. 
An important aspect of the present study is that the evaluation 
was for up to 27 weeks (half a year), which is a long in vivo 
assessment for such studies. The present data showed that after 
27 weeks all three scaffolds lost a comparable molecular weight 
of 90% of the original molecular weight. Interestingly, the nDP 
present in the scaffolds’ implantation area at week 27 suggests 
that the particles stay in the tissue even after almost 90% of 
the scaffold has degraded without eliciting side effects. The 
decrease in the pH (acidic environment) during scaffold degra-
dation leads to the agglomeration of the particles, which immo-
bilizes them and prevents adverse effects commonly induced 
by nanoscale materials. The fast degradation might be consid-
ered an undesirable feature in theory, since previous studies 
have shown that the slower the degradation, the better the host 
response, [ 28 ] but in fact this was not seen in our study, probably 
attributed to nDP and BMP-2 modifi cations. Although the nDP 
and nDP+BMP-2 scaffolds that degraded faster had elevated 
mRNA levels of proinfl ammatory markers relative to PLCL at 
week 1, the infl ammatory cells present histologically in the site, 
particularly chronic infl ammation cells, were signifi cantly less 
at the later time points. 
 Implanted materials, such as scaffolds, cause the body to ini-
tiate an infl ammatory response. This infl ammatory response 
is known as the foreign body reaction (FBR), which has three 
phases: onset, progression, and resolution. [ 31 ] The onset phase 
shares characteristics with wound healing after injury. In our 
study, implantation of the biomaterials induced tissue injury, 
which caused the release of infl ammatory mediators including 
a wide range of cytokines. Although our study did not include 
a sham surgical or “injury” control, the initial infl ammatory 
response between the scaffold groups differed, which is more 
likely to be related to the modifi cations than to the surgical 
injury. 
 The surface chemistry of an implanted scaffold strongly 
infl uences the composition of the adsorbed protein layer 
and the host response is induced indirectly by these protein 
layers. [ 31 ] Previous reports have shown that hydrophilic/neu-
tral surfaces inhibit infl ammatory cellular adhesion. [ 15 ] This 
explains the reduced number of infl ammatory cells seen in 
the nDP modifi ed scaffolds compared to PLCL scaffolds in this 
study. Hydrophilic surfaces were also shown to downregulate 
proinfl ammatory gene expression by macrophage-like cells in 
vitro. [ 32 ] The nDP modifi ed scaffold groups demonstrated the 
highest mRNA expression levels of proinfl ammatory markers 
(CCL5, IL6, TNFα, and CCL12) at week 1 postimplant. 
These elevated levels of infl ammatory cytokines from modi-
fi ed groups might be due to changes occurring in fi brinogen 
adsorption, as previous studies have shown that materials 
with hydroxyl group terminations might exhibit infl ammatory 
reactions due to their effects on fi brinogen. [ 33 ] This reduced 
infl ammatory cell count but high infl ammatory marker expres-
sion in the modifi ed groups can also be due to a negative feed-
back phenomenon, or posttranscriptional control, or increased 
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a means of reducing infl ammatory activity and of dramatically 
lowering the pharmacological dose of the osteogenic agent to a 
safe and economically feasible level. 
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The morphology of FBGC was different between the scaffold 
groups. Phenotypic differences in FBGC have been reported 
to occur as a result of material surface properties, [ 41 ] thus the 
surface created by the nDP and their agglomerates may induce 
the cells to fl atten in order to come in better contact with the 
material. 
 Upregulation of the tissue regeneration/healing markers 
IL4 and MMP-9 at week 8, when proinfl ammatory markers 
were decreasing is predictable as the phases of infl amma-
tion progress. MMP-9 has been associated with modulation 
of infl ammation by extracellular remodeling and signaling 
during a foreign body reaction. [ 42 ] Emerging evidence suggests 
the active participation of MMP-9 in clearance of infl ammatory 
cells [ 43 ] and this is refl ected here in the decrease in lymphocytes 
in the nDP scaffolds at week 8 and week 27 compared to the 
other scaffolds groups. 
 Although a capsule was seen surrounding the scaffolds his-
tologically, it was not always complete in every section, there-
fore it was evaluated when found. The consistent presence of 
BMP-2 in the vicinity of the nDP+BMP-2 may play a role in the 
thick encapsulation around that group at week 8. However, the 
fact that the capsule was signifi cantly reduced in thickness by 
week 27 in the nDP and nDP+BMP-2 groups when seen sug-
gests improved biocompatibility of these scaffolds and is an 
expected phenomenon with osteogenecity. [ 44 ] The bioactivity of 
physisorped BMP-2 was also demonstrated by upregulation of 
BMPR1A and RUNX2 by week 1, indicating activation of the 
BMP signaling pathway and a subsequent increase of osteo-
genicity. [ 45 ] This led to increased mRNA expression for ALP and 
BMP-2 in the nDP+BMP-2 scaffolds. The signifi cantly elevated 
levels of COL1a2 and COL2a1 at week 1 in nDP+BMP-2 scaf-
fold group demonstrate the presence of early osteogenic poten-
tial before mineralization. Thus, the elevated infl ammatory 
response at week 1 from the nDP modifi ed scaffolds can also 
be considered as the infl ammatory response prior to the regen-
eration process. In further support of this, micro-CT analysis 
revealed mineralization as nodules-like spreading within the 
nDP+BMP-2 scaffolds at week 8. Histologically, these sites 
of mineralization were confi rmed as a mineralization or hya-
linised cartilage. This supports previous reports from our lab 
demonstrating that this mode of binding BMP-2 to scaffold and 
delivery of a very low amount encouraged early bone formation 
in a critical size rat mandible defect. [ 12,46 ] The subcutaneous 
area is relatively lacking in circulation [ 47 ] and tissue regenera-
tion after scaffold implantation can therefore be a challenge. 
Despite this, modifi cation with nDP resulted in a signifi cant 
increase in angiogenic markers seen by week 1. In addition, a 
decrease in infl ammation as refl ected by a reduction in infl am-
matory cells at week 8 was seen. 
 In conclusion, the results presented here demonstrate that 
modifying poly[( L -lactide)-co-(ε-caprolactone)] scaffolds with 
nDP does not aggravate the tissue response in a subcutaneous 
implantation model and that this mode of physisorbed BMP-2 
delivery shows attenuation of infl ammatory responses. The 
identifi cation of functional groups in nDP that can be tailored 
to control protein adsorption and subsequent host response is 
warranted and can be of major value to the fi eld of tissue engi-
neering. In a clinical setting, nDP functionalized copolymer 
scaffolds with or without physisorbed BMP-2 would thus afford 
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